Literature DB >> 835606

Hyperphosphatermia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia.

E C Cadman, W B Lunberg, J R Bertino.   

Abstract

Hyperphosphatemia, hypocalcemia and acute oliguric renal failure resulting from uric acid nephropathy developed in a patient with Burkitt's lymphoma and Burkitt cell leukemia after effective chemotherapy. A review of other reported cases in which the patients had similar metabolic abnormalities is presented, and the pathophysiology is discussed. The clinical setting in which these metabolic developments are most likely to occur is defined, and an approach for their prevention and management is presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835606     DOI: 10.1016/0002-9343(77)90324-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Isolation of a herpesvirus-specific DNA polymerase from tissues of an American patient with Burkitt lymphoma.

Authors:  H S Allaudeen; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 2.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

3.  Effective therapy for Burkitt's lymphoma: high-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy.

Authors:  I Ramirez; M P Sullivan; Y Wang; R G Martin; J J Butler
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma.

Authors:  A Kanfer; G Richet; J Roland; F Chatelet
Journal:  Br Med J       Date:  1979-05-19

5.  Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome.

Authors:  D Heney; A Essex-Cater; J T Brocklebank; C C Bailey; I J Lewis
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

6.  Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.

Authors:  S L Saccente; E C Kohaut; R L Berkow
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

7.  The 'tumour overkill syndrome'. A potentially lethal complication of cancer chemotherapy.

Authors:  M L Slevin; R Bell; A M Cotterill; T A Lister
Journal:  Postgrad Med J       Date:  1981-11       Impact factor: 2.401

8.  Hypocalcemia in patients with prostate cancer.

Authors:  S C Kukreja; A Shanmugam; T E Lad
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

9.  Hypophosphatemia accompanying blastic crisis in a patient with malignant lymphoma.

Authors:  J Perek; M Mittelman; U Gafter; M Djaldetti
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 10.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.